ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Systemic lupus erythematosus (SLE)"

  • Abstract Number: 075 • 2020 Pediatric Rheumatology Symposium

    Pseudotumor Cerebri Syndrome in Children with Systemic Lupus Erythematosus

    Taha Moussa1, Moussa Abdelhak 2 and Cuoghi Edens 3, 1University of Chicago Medicine, Chicago, 2Cambridge GPVTS, Cambridge, United Kingdom, 3University of Chicago, Chicago

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that typically affects multiple organs and can lead to potentially fatal complications. Management of…
  • Abstract Number: 083 • 2020 Pediatric Rheumatology Symposium

    Worsening Disease Activity and Inability to Taper Corticosteroids in an Ethnically Diverse Cohort of Pediatric-Onset Lupus Patients After Transition to Adult Care

    Marla Guzman1, Anne Eberhard 1 and Joyce Hui-Yuen 2, 1Cohen Children's Medical Center, Lake Success, 2Cohen Children's Medical Center, New Hyde Park

    Background/Purpose: Transition of pediatric lupus (pSLE) patients from pediatric to adult rheumatology care is historically difficult and challenging. We aim to investigate disease activity and…
  • Abstract Number: 094 • 2020 Pediatric Rheumatology Symposium

    A Good Inter- and Intra-observer Reliability of Subtypes in Nailfold Capillary Micro-haemorrhages in Childhood-onset Systemic Lupus Erythematosus

    Sandy Bergkamp1, Dieneke Schonenberg-Meinema 2, Merlijn van den Berg 2, Vanessa Smith 3, Amber Vanhaecke 4, Karin Melsens 4, Amara Nassar Sheikh Rashid 5, Taco Kuijpers 6 and Maartje Boumans 7, 1Amsterdam Medical Center, Uithoorn, Netherlands, 2Amsterdam, Netherlands, 3Ghent University Hospital, Ghent, Belgium, 4Ghent University, Ghent, Belgium, 5Amsterdam Medical Center, Amsterdam, Netherlands, 6AMC, Amsterdam, Netherlands, 7Maxima Medical Center, Eindhoven, Netherlands

    Background/Purpose: In previous studies, micro-haemorrhages have often been observed in nailfold capillaroscopy in SLE.1 The interpretation of this finding is still a topic of research.…
  • Abstract Number: 124 • 2020 Pediatric Rheumatology Symposium

    Pharmacist Role in an Outpatient Adolescent Complex Pediatric Lupus Clinic

    Shannon Rotolo 1, Grace Cameron2, Cuoghi Edens 1 and Constentina Talevski 3, 1UCM, Chicago, 2UCM, Oak Lawn, 3Univeristy of Chicago Medicine, Lockport

    Background/Purpose: Systemic lupus erythematous (SLE) is an autoimmune disease in which the body produces pathogenic autoantibodies that cause inflammation resulting in multi-organ damage. A SLE…
  • Abstract Number: 127 • 2020 Pediatric Rheumatology Symposium

    Disease Characteristics and Medication Utilization in Lupus Nephritis Associated with Childhood-Onset Systemic Lupus Erythematosus

    Emily Smitherman1, Rouba Chahine 1, Timothy Beukelman 1, Laura Lewandowski 2, AKM Fazlur Rahman 1, Scott Wenderfer 3, Aimee Hersh 4 and Jeffrey R Curtis 5 for the CARRA investigators, 1University of Alabama at Birmingham, Birmingham, 2NIAMS, NIH, Rockville, 3Section of Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, 4University of Utah Primary Children's Hospital, Salt Lake City, 5University of Alabama at Birmingham, Hoover

    Background/Purpose: Lupus nephritis associated with childhood-onset systemic lupus erythematosus (cSLE) is a significant risk factor for long-term morbidity and mortality, but little is known regarding…
  • Abstract Number: 128 • 2020 Pediatric Rheumatology Symposium

    Predictors of Moderate/High Disease Activity in Childhood-Onset Systemic Lupus Erythematosus

    Emily Smitherman1, Rouba Chahine 1, Timothy Beukelman 1, Andrea Knight 2, AKM Fazlur Rahman 1, Mary Beth Son 3, Jeffrey R Curtis 4 and Aimee Hersh 5 for the CARRA investigators, 1University of Alabama at Birmingham, Birmingham, 2SickKids Research Institute, Toronto, Canada, 3Boston Children's Hospital, Boston, Massachusetts, 4University of Alabama at Birmingham, Hoover, 5University of Utah Primary Children's Hospital, Salt Lake City

    Background/Purpose: Substantial risk of early morbidity and mortality exists for patients with childhood-onset systemic lupus erythematosus (cSLE), but there are limited studies identifying predictors of…
  • Abstract Number: 151 • 2020 Pediatric Rheumatology Symposium

    Differences in Chromatin Architecture Between Treatment-Naïve Pediatric and Adult Lupus Patients

    Joyce Hui-Yuen1, Frank Jenkins 2, Kaiyu Jiang 3, Betty Diamond 2 and James Jarvis 4, 1Cohen Children's Medical Center, New Hyde Park, 2Northwell Health, Manhasset, 3University at Buffalo, Buffalo, 4University at Buffalo Jacobs School of Medicine, Buffalo

    Background/Purpose: Systemic lupus erythematosus (SLE) is possibly triggered by gene-environment interactions. We showed most of the SLE haplotypes contain epigenetic marks associated with enhancer function…
  • Abstract Number: 170 • 2020 Pediatric Rheumatology Symposium

    Clinical Team Perspectives on the Transition from Pediatric to Adult Care for Patients with Childhood-Onset SLE

    Nicole Bitencourt1, Justin Kramer 2, Bonnie Bermas 3, Elizabeth Solow 2, Tracey Wright 2 and Una Makris 2, 1UT Southwestern Medical Center, Dallas, Texas, 2UT Southwestern Medical Center, Dallas, 3UTSouthwestern Medical Center, Dallas

    Background/Purpose: The transition from pediatric to adult care for youth with chronic disease is known to be a vulnerable period, with adverse outcomes described for…
  • Abstract Number: 176 • 2020 Pediatric Rheumatology Symposium

    Implementation of an Abbreviated Neuropsychology Screening Protocol for Patients Diagnosed with Childhood-onset Systemic Lupus Erythematosus

    Camille Wilson1, Alana Leever 1, Jennifer Cass 1, Vidya Sivaraman 2 and Stacy Ardoin 1, 1Nationwide Children's Hospital, Columbus, 2Division of Rheumatology, Nationwide Children's Hospital, Bexley

    Background/Purpose: Research has established that a large percentage of individuals diagnosed with childhood-onset systemic lupus erythematosus (cSLE) report cognitive dysfunction. Disease factors that can impact…
  • Abstract Number: 177 • 2020 Pediatric Rheumatology Symposium

    Educational Outcomes in a Young-Adult Cohort of Patients with Childhood Onset Systemic Lupus Erythematosus (SLE)

    Anita Dhanrajani1, Earl D. Silverman 2, Andrea Knight 3, Deborah Levy 4 and Amanda Steiman 5, 1Hospital for Sick Kids, Edmonton, Alberta, Canada, 2Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 3SickKids Research Institute, Toronto, Canada, 4Division of Rheumatology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada, 5Sinai Health System, Toronto, Ontario, Canada

    Background/Purpose: The literature regarding educational and socioeconomic outcomes in young adults with childhood-onset Systemic Lupus Erythematosus (cSLE) are sparse. cSLE patients recently transitioned to adult…
  • Abstract Number: 186 • 2020 Pediatric Rheumatology Symposium

    Anthropometric Assessment and Food Intake of Parents of Pediatric Patients with Chronic Rheumatic Diseases

    Lucila Pereira1, Agatha Nogueira Previdelli 2, Rosana Gomes de Torres Rossi 2, Wellington Douglas Rodrigues 3, Fernado Luiz Affonso Fonseca 3, Claudio Len 4, Roseli Oselka Saccardo Sarni 3 and Maria Teresa Terreri 4, 1Federal University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 2Sao Judas Tadeu University, Sao Paulo, Brazil, 3Federal University of Sao Paulo, Sao Paulo, Brazil, 4Sao Paulo, Brazil

    Background/Purpose: Chronic rheumatic diseases in children and adolescents increase cardiovascular risk. Thus, knowing the eating habits, biomarkers of lipid metabolism and the lifestyle of patients…
  • Abstract Number: 032 • 2020 Pediatric Rheumatology Symposium

    The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus

    Joyce Chang1, Alaina Davis 2, Marisa Klein-Gitelman 3, Zuleyha Cidav 4, David Mandell 5 and Andrea Knight 6, 1Children's Hospital of Philadelphia, Philadelphia, 2Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee, 3Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, 4University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, 5Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 6SickKids Research Institute, Toronto, Canada

    Background/Purpose: Youth with systemic lupus erythematosus (SLE) experience significant health care burden and high rates of psychiatric disorders. Optimizing medication adherence is critical for preventing…
  • Abstract Number: 033 • 2020 Pediatric Rheumatology Symposium

    Parental Adverse Childhood Experience (ACE) Exposure Is Predictive of Active Lupus in Pediatric Patients

    Michael Nelson1, Nancy Correa 2, Ashley Butler 1, Marietta De Guzman 3, Bethanie Van Horne 1 and Christopher Greeley 1, 1Baylor College of Medicine, Houston, 2Texas Children's Hospital, Houston, 3Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas

    Background/Purpose: Adverse Childhood Experiences (ACEs) have been recognized for more than two decades as risk factors for poor health outcomes in adults. Nevertheless, the impact…
  • Abstract Number: 035 • 2020 Pediatric Rheumatology Symposium

    The Childhood and Rheumatology Research Alliance Systemic Lupus Erythematosus and Related Disorders Cohort

    Stacy Ardoin1, Stephen Balevic 2, Aimee Hersh 3, Yukiko Kimura 4, Andrea Knight 5, Laura Schanberg 6, Mary Beth Son 7 and Timothy Beukelman 8 for the CARRA investigators, 1Nationwide Children's Hospital, Columbus, 2Duke University, Hillsborough, 3University of Utah Primary Children's Hospital, Salt Lake City, 4Hackensack Meridian School of Medicine, Hackensack, 5SickKids Research Institute, Toronto, Canada, 6Duke Children's Hospital & Health Center, Durham, North Carolina, 7Boston Children's Hospital, Boston, Massachusetts, 8University of Alabama at Birmingham, Birmingham

    Background/Purpose: Optimal therapy in childhood onset systemic lupus erythematosus (SLE) lack sufficient data to support clinical decision making. To address this knowledge gap, the Childhood…
  • Abstract Number: 052 • 2020 Pediatric Rheumatology Symposium

    Nasopharyngeal Pneumococcus Colonization in Patients with Childhood Onset Systemic Lupus Erythematosus (cSLE) Compared to Healthy Controls

    Fatima Barbar-Smiley1, Stacy Ardoin 2, Chack-Yung Yu 3, Veronica Mruk 4, Cagri Yildirim-Toruner 2, Vidya Sivaraman 5, Joanne Drew 1, alexa meara 6, Asuncion Mejias 2 and Octavio Ramilo 7, 1Nationwide Children's Hospital, Columbus, Ohio, 2Nationwide Children's Hospital, Columbus, 3Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, 4The Ohio State University, Columbus, 5Division of Rheumatology, Nationwide Children's Hospital, Bexley, 6The Ohio State University Wexner Medical Center, COLUMBUS, 7Nationwide Children's Hospital, 700 Children's Drive

    Background/Purpose: Streptococcus pneumoniae (S. pneumoniae) may lead to severe life-threatening infections in both the general and immunocompromised population. Patients diagnosed with Systemic Lupus Erythematosus (SLE)…
  • « Previous Page
  • 1
  • …
  • 159
  • 160
  • 161
  • 162
  • 163
  • …
  • 181
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology